Definition and significance of polycystic ovarian morphology: a task force report from the Androgen Excess and Polycystic Ovary Syndrome Society. - Wikidata - awgldk - TriplyDB

Definition and significance of polycystic ovarian morphology: a task force report from the Androgen Excess and Polycystic Ovary Syndrome Society.

Definition and significance of polycystic ovarian morphology: a task force report from the Androgen Excess and Polycystic Ovary Syndrome Society.

http://www.wikidata.org/entity/Q34392414

about

Poly Cystic Ovarian Syndrome: An Updated Overview Can anti-Mullerian hormone replace ultrasonographic evaluation in polycystic ovary syndrome? A review of current progress Role of Anti-Müllerian Hormone in pathophysiology, diagnosis and treatment of Polycystic Ovary Syndrome: a review Value of ultrasonography in the diagnosis of polycystic ovary syndrome - literature review Anti-Müllerian hormone: ovarian reserve testing and its potential clinical implications Scientific Statement on the Diagnostic Criteria, Epidemiology, Pathophysiology, and Molecular Genetics of Polycystic Ovary Syndrome.CLINICAL PRACTICE. Polycystic Ovary Syndrome.Androstenedione response to recombinant human FSH is the most valid predictor of the number of selected follicles in polycystic ovarian syndrome: (a case-control study)Ovarian morphology is associated with insulin resistance in women with polycystic ovary syndrome: a cross sectional study Intraovarian control of early folliculogenesis The Polycystic Ovary Morphology-Polycystic Ovary Syndrome Spectrum.Relative importance of AMH and androgens changes with aging among non-obese women with polycystic ovary syndrome.Clinical utility of magnetic resonance imaging and ultrasonography for diagnosis of polycystic ovary syndrome in adolescent girls.Western-style diet, with and without chronic androgen treatment, alters the number, structure, and function of small antral follicles in ovaries of young adult monkeys Sonographic markers of ovarian morphology, but not hirsutism indices, predict serum total testosterone in women with regular menstrual cycles.Developmental Programming: Prenatal Testosterone Excess and Insulin Signaling Disruptions in Female Sheep.The Author Response: Serum anti-Müllerian hormone levels and phenotypes of polycystic ovary syndrome.Promoter methylation of yes-associated protein (YAP1) gene in polycystic ovary syndrome Animal models of hyperandrogenism and ovarian morphology changes as features of polycystic ovary syndrome: a systematic review Polycystic ovary syndrome: a common hormonal condition with major metabolic sequelae that physicians should know about.The management of patients with polycystic ovary syndrome.Technical and performance characteristics of anti-Müllerian hormone and antral follicle count as biomarkers of ovarian response.A comprehensive approach in diagnosing the polycystic ovary syndrome.Adolescence and polycystic ovary syndrome: current concepts on diagnosis and treatment.Polycystic ovary morphology: age-based ultrasound criteria.What does a diagnostic label of 'polycystic ovary syndrome' really mean in adolescence? A review of current practice recommendations.Effects of long-term exogenous testosterone administration on ovarian morphology, determined by transvaginal (3D) ultrasound in female-to-male transsexuals.Clustering of PCOS-like traits in naturally hyperandrogenic female rhesus monkeys.The management of anovulatory infertility in women with polycystic ovary syndrome: an analysis of the evidence to support the development of global WHO guidance.Outcomes of in vitro fertilization cycles among patients with polycystic ovary syndrome following ovarian puncture for in vitro maturation.Baseline AMH Level Associated With Ovulation Following Ovulation Induction in Women With Polycystic Ovary Syndrome.Maternal and neonatal outcomes in pregnant women with PCOS: comparison of different diagnostic definitions.The Pathogenesis of Polycystic Ovary Syndrome (PCOS): The Hypothesis of PCOS as Functional Ovarian Hyperandrogenism Revisited.Age-stratified thresholds of anti-Müllerian hormone improve prediction of polycystic ovary syndrome over a population-based threshold.An International Consortium Update: Pathophysiology, Diagnosis, and Treatment of Polycystic Ovarian Syndrome in Adolescence.Anti-Müllerian hormone as a marker of ovarian reserve: What have we learned, and what should we know?Health-related quality of life questionnaire for polycystic ovary syndrome (PCOSQ-50): development and psychometric properties.Counting ovarian antral follicles by ultrasound: a practical guide.Automated follicle count using three-dimensional ultrasound in polycystic ovarian morphology.Anti-Müllerian hormone reflects the severity of polycystic ovary syndrome.

P2860

Q26752564-FDA193D3-4339-472E-B266-514104DCC59B Q26773554-5805CB70-3574-4BB9-9FFE-2306AEA58A4C Q26774060-4CBAE6A6-67CF-4C44-B513-63E004638ADA Q26774941-B9E2E24E-38BE-4D28-94F6-60BA8D3734CF Q28239980-FDA5861D-01A2-4325-BF7B-AF236C9731FA Q28390200-79E7C89E-4A3D-4239-AF0F-5C0385189B9B Q29248890-4A4987B2-A0EF-4627-A00A-3E8B5D2F072B Q33667893-3D428D04-FE26-4ED0-AB28-F24D8B0AC945 Q33742664-4DC88480-EDA5-4976-A1B2-296528EB16D8 Q35024088-8F689C47-0A5A-404D-88A6-D1B39E0A9B79 Q35287911-640DA235-347F-454F-A386-B326006266F9 Q35834587-DA195195-CE5D-4553-9A65-483B76523D99 Q36240566-0C20D33B-1A67-4F1E-9766-C20FC21E7000 Q36767622-19281E54-F70D-4396-8459-15BD8936BA48 Q36895576-4237A096-ABEE-478E-8388-7FE3E3737766 Q37082089-93CC19D7-7688-464C-AA9A-07CBB75F3B87 Q37555122-E315D700-349B-408B-A57B-6412216F7C7E Q37606345-D2E07CA2-37E0-4090-A5B2-C3458509CDCF Q37635279-6EA81411-4C77-43AF-AF90-B66BC2536994 Q38218598-96CBA336-5E7B-43EE-A13E-68628ABA76A7 Q38229280-45259FD7-0D1E-4B5B-8572-C88B76E790A6 Q38285639-4F42477E-F774-4544-983B-4297073D22C0 Q38371865-DEF7E9DA-D40C-475A-B254-C6911267C4B9 Q38569694-32A5DF1C-934B-4137-A00C-1C1B2B488B06 Q38625298-E8DC7662-4DEC-4A5B-B51B-42A0EC6967F0 Q38633475-0301C40D-A48E-4A92-999C-1F99D72744EA Q38785823-ADDCD5D9-2175-4F0A-AE36-DAE9BE8F0D50 Q38883826-9DA886B3-0B25-419E-A31F-63AD41B1F959 Q38924361-B6A97C62-B84A-40E8-8EA0-92C6FA2AFA11 Q39194522-50E789D1-5C4F-4040-8A4A-3FE4C2121644 Q39734053-B9DF46FB-D4DD-4E20-B71A-A2EE03B435D6 Q40680864-B024068D-CDDC-4E45-B1F0-CDD301F7F345 Q41640666-A1B758A3-E28A-4044-9F47-58BD59C7130E Q45062761-F30D0AB5-8100-4459-8AA1-ED06BC20526E Q46552680-E35B3A18-CFE8-44A2-BB1E-AA2289F40FDA Q47170320-FFFBC13F-FFA2-4580-B8FA-4EAA0C268AB8 Q47591036-6548F2BE-38DD-4C3D-8A20-D73FB0E55851 Q47871435-2562303A-DCE1-47CD-A525-DED4586AD0CA Q48121550-C477B87C-FBBC-44FB-A2AC-77F47DB2F281 Q48253033-78D06385-3E0A-4787-93A9-1AD87CF6627E

P2860

Definition and significance of polycystic ovarian morphology: a task force report from the Androgen Excess and Polycystic Ovary Syndrome Society.

http://www.wikidata.org/entity/Q34392414

description

2013 nî lūn-bûn

@nan

2013 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2013 թվականի դեկտեմբերին հրատարակված գիտական հոդված

@hy

2013年の論文

@ja

2013年論文

@yue

2013年論文

@zh-hant

2013年論文

@zh-hk

2013年論文

@zh-mo

2013年論文

@zh-tw

2013年论文

@wuu

name

Definition and significance of ...... cystic Ovary Syndrome Society.

@ast

Definition and significance of ...... cystic Ovary Syndrome Society.

@en

Definition and significance of ...... cystic Ovary Syndrome Society.

@nl

type

label

Definition and significance of ...... cystic Ovary Syndrome Society.

@ast

Definition and significance of ...... cystic Ovary Syndrome Society.

@en

Definition and significance of ...... cystic Ovary Syndrome Society.

@nl

prefLabel

Definition and significance of ...... cystic Ovary Syndrome Society.

@ast

Definition and significance of ...... cystic Ovary Syndrome Society.

@en

Definition and significance of ...... cystic Ovary Syndrome Society.

@nl

P1433

Q34392414-3F1C33A7-EB99-4FE2-9EDC-18E1D9D0967D

P1476

Q34392414-524243A8-2187-459A-A70D-70376A48FEA4

P2093

Q34392414-1D7028D2-D701-42DA-8780-D61DDC1EFDCB

Q34392414-3625C203-1E2E-4A1A-BB83-9EE70B23CC6F

Q34392414-67AA9D2B-C658-4F60-A4E2-BEDCDF2A127F

Q34392414-696A88C2-D13C-4238-A553-96909B544A5B

Q34392414-CC5A5E47-0AFC-4AF7-8C8E-E64F4915381E

P2860

Q34392414-0ADC01C6-0B6D-4B49-8D7C-F3E3BA9144D6

Q34392414-0D6D77B8-AD08-4B93-8777-F4FAE1E26DC3

Q34392414-0F2F0791-CAFD-42A1-872F-B259774DBD0A

Q34392414-117BD782-5306-44C7-837F-ADADA8B3878D

Q34392414-11A9537C-032B-443E-B665-CED3310BFD3C

Q34392414-125F919E-F7C0-4744-BF96-26F3F95B7812

Q34392414-135C1268-ED32-4D22-BB89-7430CC5491F1

Q34392414-144833E4-AACC-438B-A228-2F9DD1E79D2E

Q34392414-1467F9B1-C033-4E7F-8B13-5F1CAB54F558

Q34392414-16CE77B6-D8D9-4955-B2BB-F37BBDAB3BC5

P304

Q34392414-E1D0641F-FFF6-48D1-A522-96016DBC534C

P31

Q34392414-7FDB9EB3-CA2C-4FDE-B2BD-B7728FE331E1

P356

Q34392414-2991126D-DDED-4F6D-BED0-DBAADF918689

P433

Q34392414-94280A57-3A7F-4EFC-B755-466EAD8275C9

P478

Q34392414-B6ADD759-0C6A-4243-87AC-00F01AA641FF

P50

Q34392414-265C1A5C-00FB-4DCF-A6EB-852C80964A2F

Q34392414-6488E966-E106-48D4-B54D-B094097E7A01

P577

Q34392414-4808C6C2-8006-411B-8DF7-91089BC4097D

P5875

Q34392414-90CD9F50-A90F-4E51-A4F0-47A848074550

P698

Q34392414-F6B7511D-2082-4941-B9F7-BFF9CC997242

P921

Q34392414-B23A8D34-05FF-4DFA-8218-EBE8C372FE29

P356

P1433

Human Reproduction Update

P1476

Definition and significance of ...... cystic Ovary Syndrome Society.

@en

P2093

Enrico Carmina

http://www.w3.org/2001/XMLSchema#string

Joop Laven

http://www.w3.org/2001/XMLSchema#string

Marcelle I Cedars

http://www.w3.org/2001/XMLSchema#string

Marla E Lujan

http://www.w3.org/2001/XMLSchema#string

Robert J Norman

http://www.w3.org/2001/XMLSchema#string

P2860

Grading quality of evidence and strength of recommendations

AMH and AFC as predictors of excessive response in controlled ovarian hyperstimulation: a meta-analysis

Psychological stress and reproductive aging among pre-menopausal women

Criteria for Defining Polycystic Ovary Syndrome as a Predominantly Hyperandrogenic Syndrome: An Androgen Excess Society Guideline

Improving inter-observer variability in the evaluation of ultrasonographic features of polycystic ovaries.

The interobserver reliability of off-line antral follicle counts made from stored three-dimensional ultrasound data: a comparative study of different measurement techniques.

The interobserver reliability of three-dimensional power Doppler data acquisition within the female pelvis.

Grid analysis improves reliability in follicle counts made by ultrasonography in women with polycystic ovary syndrome.

Anti-Müllerian hormone and polycystic ovary syndrome: a mountain too high?

Insulin-mediated skeletal muscle vasodilation is nitric oxide dependent. A novel action of insulin to increase nitric oxide release

P304

334-352

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1093/HUMUPD/DMT061

http://www.w3.org/2001/XMLSchema#string

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

20

http://www.w3.org/2001/XMLSchema#string

P50

Héctor F Escobar-Morreale

Didier Dewailly

P577

2013-12-16T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

259351942

http://www.w3.org/2001/XMLSchema#string

P698

24345633

http://www.w3.org/2001/XMLSchema#string

P921

polycystic ovary syndrome